Last reviewed · How we verify

NCT03495531

Virtual Reality in Obstetric Patients

Completed NA Last updated 27 September 2021
What this trial tests

NA trial testing Virtual Reality in Obstetric Pain in 60 participants. Completed in 11 March 2021.

Timeline
3 July 2018
Primary endpoint
11 March 2021
11 March 2021

Quick facts

Lead sponsorStanford University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment60
Start date3 July 2018
Primary completion11 March 2021
Estimated completion11 March 2021
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Stanford University

Who can join

18 and older, female only, with Obstetric Pain or Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to determine if non-invasive distracting devices (Virtual Reality headset) are more effective than the standard of care (i.e., no technology based distraction) for preventing anxiety and pain scores in women who are undergoing child laboring procedures. The anticipated primary outcome will be a reduction of pregnant females overall anxiety and pain scores before and after such procedure(s), including but not limited to epidural/combined spinal epidural (CSE), IV placement and/or labor.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Virtual Reality

Trials testing the same drug.

Other recruiting trials for Obstetric Pain

Currently open trials in the same condition.

Other Stanford University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03495531.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing